Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
New

VYNE
VYNE Therapeutics Inc
stock NASDAQ

At Close
1/18/2022 3:59:25 PM EST
0.6801USD-1.019%(-0.0070)1,515,630
0.7100Bid   0.7300Ask   0.0200Spread IEX
Pre-market
1/18/2022 9:07:13 AM EST
0.7300USD+6.244%(+0.0429)1,505
After-hours
1969-12-31
0.00USD0.000%(0.00)0
OverviewNewsOption ChainHistoricalStats
open chart   
open chart   
Market Cap
36.398M
Industry
Biotechnology
Next Earnings
2022-03-03 (43d)
Last Split
2021-02-161for4reverse
Dec 6, 2021
06:31AM EST  HC Wainwright & Co. Assumes VYNE Therapeutics at Buy, Announces Price Target of $7   Benzinga
Nov 18, 2021
08:00AM EST  VYNE Therapeutics Inc. (Nasdaq: VYNE) (VYNE or the Company) today announced that David Domzalski, Chief Executive Officer, will present at the upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference.   GlobeNewswire Inc
Nov 11, 2021
11:55AM EST  VYNE Therapeutics's Return On Capital Employed Insights   Benzinga
Nov 10, 2021
07:53AM EST  VYNE Therapeutics Q3 EPS $(0.36) Misses $(0.32) Estimate, Sales $4.09M Miss $4.76M Estimate   Benzinga
07:51AM EST  VYNE Therapeutics Q3 Loss Per Share $0.41; Adj Loss Per Share $0.36   RTTNews
More News
Stats
Avg. Vol. 10 Day
4,830,548
Avg. Vol. 30 Day
2,071,366
Employees
106
Market Cap
36,397,532
Shares Out.
53,517,912
Float
51,927,360
On/Off Exchange
50%/50%
6 Month Beta
1.93
1 Year Beta
1.89
2 Year Beta
0.88
3 Year Beta
0.92
52 Week Low
0.65
52 Week High
11.20
SMA50
1.07
SMA200
1.61
1 Week
-34.61%
1 Month
-37.03%
3 Month
-40.34%
6 Month
-75.27%
1 Year
-90.45%
2 Year
-97.46%
5 Year
-99.40%
Profile
VYNE's mission is to improve the lives of patients by developing proprietary, innovative and differentiated therapies in dermatology and beyond.

VYNE Stock Summary

VYNE Therapeutics Inc (NASDAQ:VYNE) stock price today is $0.6801, and today's volume is 1,515,630. VYNE is down -1.019% today. The 30 day average volume is 2,071,366. VYNE market cap is 36.398M with 53,517,912 shares outstanding.





About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
© 2020 - 2022 ChartExchange LLC